Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. (Q34086275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marie Louise De Bruin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

D Patel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A M Gallagher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

30 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

654-665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Does diabetes therapy influence the risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Insulin glargine and malignancy: an unwarranted alarm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Cancer risks in thiazolidinedione users compared to other anti-diabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Long-term metformin use is associated with decreased risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2390-3

Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study

21 January 2018

1 reference

12 December 2020

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

1 reference

12 December 2020

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

1 reference

12 December 2020

Intensive glucose control and risk of cancer in patients with type 2 diabetes

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

1 reference

12 December 2020

Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies

1 reference

12 December 2020

10.1007/S00125-011-2390-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127412%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 January 2020

1000118995

0 references

1 reference